Professor Geoff Pilkington BSc PhD CBiol FRSB FRCPath
Professor of Cellular and Molecular Neuro-oncology &
Head of Centre
Professor Pilkington has spent his entire career in brain tumour research, having started work on chemical neuro-carcinogenesis where he studied brain cancer stem cells and brain tumour development at the Middlesex Hospital Medical School in the early 1970s and subsequently spent 23 years at the Institute of Psychiatry, King’s College, London, latterly as Professor of Experimental Neuro-oncology. In 2003 he moved to the School of Pharmacy & Biomedical Sciences, University of Portsmouth, as Professor of Cellular & Molecular Neuro-oncology & Director of Research. Over the years the research focus of his group has been development of models for the study of intrinsic brain tumours, elucidation of the mechanisms underlying diffuse local invasive behaviour in glioma, delivery systems for passage of agents across the blood-brain barrier (BBB) and development of novel strategies for mitochondrial mediation of apoptosis in glioma. He has published numerous papers on the results of his research on human glioma and has developed various “all human” three-dimensional in vitro models to study brain tumour invasion and the BBB. At the University of Portsmouth he has established an excellent suite of laboratories and a host of state-of-the-art equipment in which to accommodate the Brain Tumour Research Centre.
Professor Pilkington holds a BSc (2.1) in Life Sciences and a PhD in Neuropathology (University of London). He is also a Fellow of the Royal Society of Biology, a Fellow of the Royal College of Pathologists and a Fellow of the Royal Society of Medicine. He is also the immediate Past-President of the British Neuro-oncology Society and currently Honorary Treasurer and Executive Board Member of the European Association of Neuro-oncology. He also holds membership of the British Neuroscience Association, the British Neuropathological Society (formally a committee member and Programme Secretary), the Society of Neuro-oncology, and the European Association for Cancer Research. He was instrumental in the formation of Brain Tumour UK (now integrated into The Brain Tumour Charity). He has also served as advisor to Brainstrust, Ali’s Dream and Charlie’s Challenge as well as formerly holding membership of the Samantha Dickson Brain Tumour Trust (now The Brain Tumour Charity) Scientific & Medical Advisory Board. He has also worked closely with Hammer Out (now Brain Tumour Support) and the Brain Tumour Research Campaign. He has supervised over 30 PhD students and has examined an additional 33 at various universities, both nationally and internationally, and is a member of the Scientific Advisory Board of Children with Cancer UK. In addition, he is currently Neuro-oncology Editor for Oncology News, and serves on the Editorial Boards of five journals. He has also acted as a referee for 58 journals and 42 grant awarding bodies in Europe, North America, New Zealand, Australia and Singapore. He is also a regular attendee at the quarterly All Party Parliamentary Group meetings on Brain tumours at Westminster and has served on expert advisory panels on drug repurposing and brain tumour research funding.
T: +44 (0)2392 843562